Table 5 Distribution frequency of FSCN1 haplotypes in healthy controls and patients with breast cancer.

From: FSCN1 gene polymorphisms: biomarkers for the development and progression of breast cancer

Haplotype block

Controls N = 444 (%)

Patients N = 632 (%)

OR (95% CI)

AOR (95% CI)

rs56156320

rs3801004

A/C

C/G

A

C

372 (83.8)

495 (78.3)

Reference

 

C

C

58 (13.1)

115 (18.2)

1.490 (1.057–2.100)*

1.674 (1.150–2.437)*

C

G

14 (3.2)

21 (3.3)

1.127 (0.566–2.246)

1.386 (0.662–2.901)

A

G

0 (0)

1 (0.2)

─

─

  1. The odds ratios (ORs) with their 95% confidence intervals (CIs) were estimated by logistic regression analysis. The adjusted odds ratios (AORs) with their 95% CIs were estimated by multiple logistic regression analysis that controlled for smoking, alcohol consumption, and age. *p < 0.05 was statistically significant.
Back to article page